Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United Arab Emirates

 

Al Noor rears its ugly head in Mediclinic results

Mediclinic saw underlying EBITDA fall by 2.2% in the financial year 2017, described as “humbling” by its CEO, as challenges in the Middle East made their mark on its full year results.

Good news for Abu Dhabi operators

The Abu Dhabi government had made a U-turn on its July 2016 decision to impose a 20% co-pay on private services for Thiqa cardholders. It has also lifted all IVF-related restrictions. This is good news for private operators present in the emirate, including NMC and Mediclinic.

Saudi beckons for UAE’s National Reference Lab

National Reference Laboratory (NRL), a fast growing lab network in the United Arab Emirates, which has partnered with the Laboratory Corporation of America (LabCorp), wants to become a regional player and is now looking beyond the UAE. We spoke to its marketing manager, Dr Bisera Laksinka.

Sovereign cure for Russian cancer

Abu Dhabi’s sovereign wealth fund has joined up with its Russian peer to invest $28.4m into cancer hospitals in the Moscow region opening by the end of 2017.

Kuwait – the quiet niche

Kuwait gives its 3.7m ex-pats the healthcare equivalent of the deal of the century. But for how much longer?

Find Us